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Abstract 16 
Cancers arise through the process of somatic evolution fuelled by the inception of somatic 17 
mutations. We lack a complete understanding of the sources of these somatic mutations. 18 
Humans host a vast repertoire of microbes collectively known as the microbiota. The 19 
microbiota plays a role in altering the tumour microenvironment and proliferation. In 20 
addition, microbes have been shown to elicit DNA damage which provides the substrate for 21 
somatic mutations. An understanding of microbiota-driven mutational mechanism would 22 
contribute to a more complete understanding of the origins of the cancer genome.   Here 23 
we review the modes by which microbes stimulate DNA damage and the effect of these 24 
phenomena upon the cancer genomic architecture, specifically in the form of mutational 25 




Origin of the cancer genome and the role of the microbiota 28 
Oncogenesis is driven by the Darwinian selection of somatic mutations (see Glossary) over 29 
time [1]. Mutations arise through the formation of genetic aberrations and their subsequent 30 
interactions with the DNA repair machinery and cell cycle related pathways including DNA 31 
synthesis[2]. Mutational mechanisms alter the DNA in distinguishing manners resulting in 32 
genetic patterns known as mutational signatures (Box 1).  33 
The origin of mutations allows them to be classified into three categories, which are (i) 34 
inherited genetic variants that lead to an increase in the risk of cancer development. (ii) 35 
Environmental factors, exogenous factors including UV light, tobacco smoking and diet that 36 
mutate the DNA and that are directly linked to cancer. (ii) Stochastic errors associated with 37 
DNA replication and other phenomena. These are seemingly inevitable random mutations 38 
which arise due to the intrinsic properties of DNA biology. Seminal work by Tomasetti and 39 
Vogelstein showed that about two-thirds of the mutations in the cancer genome originate 40 
from stochastic events [3, 4].  41 
Lung and cervical adenocarcinoma genomes harbour median values of 33% and 83% 42 
stochastic mutations respectively [3]. However, epidemiologic evidence indicates that a high 43 
proportion (~90%) of cases are attributable to environmental factors, i.e. tobacco smoking 44 
and HPV infection, respectively. The managing of environmental risk factors is thus crucial in 45 
cancer prevention, even though stochastic/replicative mechanisms are the major drivers 46 
(See ref 3 for a more detailed discussion). However a complete catalogue of environmental 47 
factors that contribute cancer risk is lacking. A large number of known carcinogens promote 48 
oncogenesis by causing mutagenesis e.g. ultraviolet light, ethanol, tobacco smoke and 49 
radioactive substances. 50 
The human microbiota is increasingly recognized as an emerging environmental risk factor. 51 
The human microbiota is home to about 3.8 x 1013 bacterial cells and it is estimated that the 52 
collective metagenome of these bacteria encompasses about 100 times more genes than 53 
the human genome [5, 6]. Although the majority of studies focus on bacteria, upon which 54 
this review is focussed, the human microbiota includes members from all 5 kingdoms of life 55 
as well as viruses. A large number of studies demonstrate that microbiota features are 56 
involved in the development and progression of a range of cancers. The term ‘oncobiome’ 57 
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has been coined to describe the relationship between the microbiota and cancers[7].  58 
However, oncobiome research has identified relationships that are primarily correlative 59 
rather than causative in nature. With regard to the putative mechanistic role that the 60 
microbiota has in cancer development, immune modulation in the form of inflammation 61 
caused by the microbiota is an intense area of research [8]. Effort has also been made in 62 
defining the role of the microbiota in cell proliferation [9]. 63 
The microbiota is known to be involved in a diverse assortment of mutational mechanisms 64 
(Table 1).  Known variation in cancer risk due to unknown environmental factors could be 65 
explained in part by variations in the ability of the microbiota of individual subjects to 66 
induce DNA-damage and thus somatic mutations. Here we describe the current state of 67 
knowledge on microbes and their ability to compromise the stability of the human genome 68 
ultimately leading to cancer.  69 
In this review we describe the microbiota influences on genome integrity through (i) direct 70 
DNA damage, (ii) immune cell induced DNA damage, (iii) dietary interaction, and (iv) 71 
disruption to the DNA damage response. 72 
 73 
Direct DNA Damage 74 
Members of the microbiota can produce proteins, molecules and secondary metabolites 75 
that can directly cause DNA damage.  These products can interact directly with the host 76 
DNA thereby mutating it.  77 
 78 
Colibactin 79 
Escherichia coli is classified into 4 phylogenetic groups, A, B1, B2, and D.  About 30–50% of 80 
E. coli strains identified in stool microbiota of individuals from high-income nations belong 81 
to group B2. Within the B2 group, 35% of isolates possess genomic islands known as pks (for 82 
polyketide synthase) islands[10].  The 54-kb pks island is a biosynthetic gene cluster 83 
encoding for a non-ribosomal peptide synthetase (NRPS)–polyketide synthase (PKS) hybrid 84 
gene cluster, which encodes for colibactin [11]. Colibactin can cause Double-strand breaks 85 
(DSB) in mammalian DNA thereby promoting genome instability and an increase in mutation 86 
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rate [12, 13]. It is not currently known how colibactin is transported from the cell exterior all 87 
the way into the nucleus. The pks+ E. coli strains are over-represented in the gut of 88 
individuals with colorectal cancer, being detected at a rate of 20% in the mucosa of healthy 89 
individuals but  55%-67% in patients with colorectal cancer (CRC) [14, 15]. Furthermore, 90 
pks+ E. coli was disproportionally frequently identified in subjects with familial 91 
adenomatous polyposis (FAP) compared to healthy controls [16].  Monocolonization of 92 
azoxymethane (AOM)–treated IL10−/− mice with pks+ E. coli promoted tumorigenesis, while 93 
challenge with strains lacking pks reduces the frequency of tumorigenesis [14].   94 
Colibactin cross-links directly with DNA through an electrophilic cyclopropane moiety 95 
‘warhead’ [17]. Liquid chromatography–mass spectrometry-based methodologies have 96 
identified that colibactin alkylation of DNA via the cyclopropane warhead results in adenine-97 
colibactin adducts [18, 19]. This phenomenon was identified in both HeLa cells and in mouse 98 
models [19]. Colibactin can also induce DNA inter-strand cross-links and activation of the 99 
DNA damage response including Fanconi anemia DNA repair [20]. Recent structural analysis 100 
revealed that colibactin contains two conjoined warheads enabling its ability to cause DNA 101 
crosslinks [21]. Double strands breaks are not believed to be a direct consequence of 102 
colibactin activity but rather occur due to replication stress caused by DNA cross-links [20]. 103 
Recent sequencing analysis of colibactin-induced DSB sites revealed that these DSBs 104 
occurred at AT-rich regions and in particularly at the pentanucleotides motif containing 105 
AAWWTT [22]. Single nucleotide variants at the AAWWTT were found to be enriched in a 106 
number of cancers including CRC and stomach cancer compared with a WWWWW motif. 107 
Two mutational signatures were found to be linked with the AAWWTT colibactin motif, 108 
SBS28 and SBS41[22]. Mutational signature SBS28 has been associated with POLE mutation 109 
while Mutational signature SBS41 has no known aetiology. 110 
 111 
Cytolethal distending toxin (CDT) 112 
The cytolethal distending toxin (CDT) is produced by an array of gram-negative bacteria 113 
within the gamma and epsilon classes of the phylum Proteobacteria[23].  It is a heat-labile 114 
exotoxin whose properties lead it to be classified as a both a cyclomodulin and a genotoxin. 115 
5 
 
The proteobacteria that can produce CDT are sub-dominant members of the human gut 116 
microbiota.  117 
CDT is a heteromultimeric protein comprised of three subunits, CdtA, CdtB and CdtC 118 
which are encoded within a bacterial single operon [24, 25]. Subunits CdtA and CdtC 119 
function to allow delivery and internalization of CDT into target cells[25]. CdtB shares 120 
sequence, structural and functional homology with DNase I and is highly conserved among 121 
bacteria [26, 27]. Furthermore, nuclear localization signals have been identified in CdtB 122 
proteins [28].  Studies with ApcMin/+ mice that are genetically susceptible to small bowel 123 
cancer found that a Campylobacter jejuni strain harbouring the CDT operon promoted 124 
colorectal tumorigenesis compared to treatment with non-CDT bacterial controls, while 125 
mutation of the cdtB subunit attenuated this phenomenon [29]. CdtB has been shown to 126 
promote DSB in vitro and in vivo [26, 30, 31]. However, the current model of CdtB activity 127 
holds that CdtB acts in a dose-dependent manner and tends not to induce double strand 128 
breaks directly [32]. At low to moderate doses, CdtB causes single strand breaks (SSB) which 129 
are addressed by Single-strand break repair (SSBR)[33]. If CDT-induced SSBs are not 130 
addressed before replication or occur during replication, they may cause a stalled 131 
replication fork [32, 33].  At high doses, CDT can induce DSB directly by two cuts to the DNA 132 
backbone that are juxtaposed to each other [32] .  133 
 134 
Reactive oxygen species 135 
Reactive oxygen species (ROS) are a chemically reactive family of molecules containing 136 
oxygen which include the highly reactive hydroxyl radical (OH−), superoxide radical (O2−), 137 
and non-radical hydrogen peroxide (H2O2).  Reactions of ROS with DNA generates oxidative 138 
DNA base lesions. To date, more than 30 oxidative DNA base lesions have been 139 
identified(Box 2)[34]. 140 
Microbiota activity is known to produce reactive oxygen species through varied means. For 141 
example, primary bile acids, cholic acid (CA) and chenodeoxycholic acid; (CDCA) are 142 
synthesised by the liver and are secreted into the small intestine from the gall bladder. A 143 
small proportion of these bile salts are transformed into secondary bile salts by the gut 144 
microbiota.  These secondary bile salts are thought to be involved in the production of ROS 145 
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[35]. The production of secondary bile in the colon where the bacterial metabolic repertoire 146 
exist maybe be one of the reasons that CRC is more prevalent than small intestine cancer 147 
although differences in stem cell turnover is likely a more important factor[3]. 148 
Hydrogen sulphide (H2S) is produced by the metabolic activity of colonic bacteria including 149 
taurine desulfonation by Bilophila wadsworthia, cysteine degradation by Fusobacterium 150 
nucleatum and sulfonate degradation by sulfate-reducing bacterium such as Desulfovibrio 151 
desulfuricans. Increased relative abundance of such bacteria has been linked to CRC 152 
development [36, 37].  Evidence suggests that H2S production leads to DNA damage partly 153 
due to ROS generation [37, 38].  154 
Dinitrogen trioxide and nitrosative deamination 155 
Nitrosative deamination is deamination mediated by dinitrogen trioxide (N2O3, nitrous 156 
anhydride). In this phenomenon, dinitrogen trioxide can react with nucleotides and induce 157 
deamination by nucleophilic aromatic substitution. These events are mutagenic because the 158 
resulting deaminated bases may be read incorrectly if not repaired[39]. 159 
Dinitrogen trioxide can be generated from the autooxidation of nitric oxide (NO-) or the 160 
condensation of nitrous acid (HNO2)[40]. GIT microbes can produce endogenous nitric oxide 161 
and/or nitrous acid by four mechanisms: (i) The hemethiolate monooxygenase, nitric oxide 162 
synthase (NOS), oxidises L-arginine (Arg) to produce nitric oxide [41] (ii) Denitrification of 163 
nitrate (NO3-) to nitrogen (N2), which is an important part of the nitrogen cycle and is carried 164 
out by denitrifying bacteria and plants. During denitrification, nitric oxide is produced by 165 
one-electron reduction of nitrite (NO2-) by heme or Cu-containing nitrite reductases[42]. (iii) 166 
Respiratory nitrite ammonification (also referred to as dissimilatory nitrate reduction to 167 
ammonium)[42]. (iv) Acidic non-enzymatic reduction of nitrite to NO which is driven by 168 
lactic acid bacteria such as lactobacilli and bifidobacteria[43]. 169 
 170 
Immune cell induced DNA damage 171 
The microbiota and immune system closely interact from the early stages of human 172 
development. In this section we review mechanisms by which the microbiota can influence 173 





Hypochlorous acid (HOCl) production 177 
Neutrophils, which are a type of polymorphonuclear leukocyte, accumulate at sites of injury 178 
with the primary function of promoting inflammation. Neutrophils produce a potent 179 
antimicrobial known as hypochlorous acid (HOCl) which is produced by myeloperoxidase 180 
using as substrates the chloride ions and hydrogen peroxide (H2O2) produced by NADPH 181 
oxidase [44]. HOCl is highly reactive and readily interacts with DNA. HOCl has been shown to 182 
cause a cytosine to 5-chlorocytosine (5ClC) conversion [45]. This is in turn can cause a C to T 183 
transition during replication. 184 
In addition, HOCl can induce the peroxidation of lipids leading to the formation of 185 
malondialdehyde (MDA). Studies in both cellular and animal models found that such a 186 
production of MDA can lead to a significant increase in the formation of 3-(2-deoxy-β-D-187 
erythro-pentofuranosyl)pyrimido[1,2-α]purin-10(3H)-one (M1dG) , a damaged  guanine. 188 
[46]. M1dG adducts are mutagenic causing G>T and G >A substitutions.[47] 189 
The microbiota is now known to be a modulator of neutrophilic biology[48]. A recent study 190 
in a mouse model demonstrated that neutrophil pro-inflammatory activity correlates 191 
positively with neutrophil ageing while in circulation[49]. Furthermore the study found that 192 
the microbiota regulates neutrophil ageing by Toll-like receptor and myeloid differentiation 193 
factor 88-mediated signalling pathways[49]. A depletion of the microbiota was mirrored in 194 
the number of aged neutrophils and an improvement in inflammatory disease.  195 
 196 
Hypobromous acid production  197 
Eosinophils are granular leukocytes with a multifunctional role in immune biology.  198 
Eosinophils secrete eosinophil peroxidase which catalyzes the formation of hypobromous 199 
acid (HOBO) from hydrogen peroxide and halide ions (Br−) in solution. HOBO can also be 200 
produced by reaction of HOCl with Br- ions. Like HOCl, HOBO is an oxidant and functions to 201 
oxidize the cellular components of invading pathogens; however excess production of HOBO 202 
can also lead to host damage including DNA damage, namely the formation of 8-bromo-2′-203 
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deoxyguanosine and 5-bromo-2′-deoxycytidine. A SupF forward mutation assay in human 204 
cells found that the prominent mutation induced was G >T mutation but HOBO also induces 205 
G>C, G>A, and delG [50]. 206 
 207 
Activation-induced cytidine deaminase 208 
Activation-induced cytidine deaminase (AID) is a member of the cytidine deaminase family 209 
of enzymes with a role in somatic hypermutation. Immunohistochemistry identified the 210 
ectopic overexpression of AID in inflamed tissue derived from patients with Crohn’s disease 211 
and ulcerative colitis as well as colitis-associated colorectal cancers [51]. The expression of 212 
AID in colonic epithelial cell lines induced an increase in the mutation rates in these cells 213 
[51]. Knock-out of AID in IL10 null mice attenuated the mutation rate in their colonic cells 214 
and also inhibits CRC development[52]. Inflammation seems to be key to this aberrant 215 
activity. H. pylori infection, which is known to induce inflammation, promotes ectopic 216 
expression of AID in non-tumorous epithelial tissues [53] 217 
Whole genome analyses in chronic lymphocytic leukaemia revealed that the activity of AID 218 
may produces two types of substitution pattern (i) a ‘canonical AID signature’ characterised 219 
by C to T/G substitutions at WRCY motifs near active transcriptional start sites and (ii) a 220 
‘non-canonical AID signature’ characterised by A to C mutations at WA (W=A or T) motifs 221 
occurring genome-wide in a non-clustered fashion [54]. These mutational processes have 222 
been assigned to mutational signatures SBS84 and SBS85[55]. 223 
 224 
By-stander effect and Enterococcus faecalis  225 
Enterococcus faecalis is known to promote CRC oncogenesis in interleukin 10 -/- mice [56]. 226 
E. faecalis can promote the bystander effect which leads to double-stranded DNA breaks, 227 
tetraploidy and chromosomal instability.   In this model, E. faecalis production of 228 
extracellular superoxide induces polarization of macrophages to an M1 phenotype [57-59]. 229 
In turn macrophages produce 4-hydroxy-2-nonenal (4-HNE), a diffusible breakdown product 230 
of ω-6 polyunsaturated fatty acids whose expression in this context is dependent on 231 
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Cyclooxygenase-2[60, 61]. Primary murine colon epithelial cells exposed to polarized 232 
macrophages or purified 4-HNE undergo transformation [62]. 233 
Dietary interaction 234 
The diet of the host and the gut microbiota are inextricably linked. GIT bacteria depend 235 
almost exclusively on the host diet for their nutritional substrates (a restricted number of 236 
taxa can metabolize mucins and glycoproteins) and indeed the composition of the 237 
microbiome is correlated strongly with diet. Diet is a key modulator of cancer risk. In the 238 
cases described below, microbiota-diet interactions lead to the formation of genotoxic 239 
compounds capable of mutating the host genome. 240 
 241 
N-nitroso compounds (NOCs) 242 
NOCs, such as nitrosamines and nitrosamide, are known to be potent carcinogens.  NOCs 243 
are formed by the nitrosation of secondary amines and amides via nitrosating agents, such 244 
as N2O3 and N2O4 [63]. NOCs can be found in foods such as processed meats, smoked/cured 245 
fish and German beer[64]. Additional compounds such as nitrate and nitrite which are 246 
precursors to nitrosating agents can be found in food including vegetables which may 247 
account for 50–70% of an individual’s intake of nitrate and nitrite [65]. Endogenous NOCs 248 
are also formed and in many cases, this is because of the activities of microbes. Firstly, 249 
bacteria produce nitrosating agents (See Dinitrogen trioxide and nitrosative deamination). 250 
Further amines and amides are produced by bacterial decarboxylation of amino acids [65]. 251 
Heme has been suggested to catalyse the formation of NOCs[66]. Inhibitors of nitrosation 252 
are ingested as part of a diet and include vitamin C, vitamin E and polyphenols[67].  253 
The activated form of NOCs induce a number of methylated DNA adducts (of which over 12 254 
are known) by  SN1-nucleophilic substitution[68]. These alkylated DNA bases can be 255 
mutagenic if not repaired before replication[69]. SBS mutational signature 11 has been 256 





Alcohol is classified as a Group 1 carcinogen (carcinogenic to humans). Worldwide, 3.6% of 260 
all cancer deaths and 3.5% of all cancer cases are attributable to alcohol consumption[71]. 261 
Ethanol (C2H5OH), the psychoactive ingredient in alcoholic beverages, is believed to be the 262 
major causative compound of cancer in alcoholic beverages. 263 
Ethanol is introduced into a catabolic pathway where it is broken down and the metabolites 264 
expelled via the urinary system. Ethanol is first metabolized by alcohol dehydrogenase 265 
(ADH), cytochrome P4502E1 (CYP2E1) and catalase thereby forming acetaldehyde (ethanal). 266 
Acetaldehyde is further oxidised by aldehyde dehydrogenase to produce acetate.  267 
Aldehydes cause DNA damage in the form of double strand breaks and the Fanconi anaemia 268 
pathway is responsible for the repair of this damage [72].  Aldehydes has been 269 
demonstrated to cause intrastrand crosslink between adjacent guanine bases[73]. This can 270 
lead to the mutagenic event of GG>TT double base substitution which is a characteristics of 271 
Mutational signature DBS2 [55, 73]. 272 
Bacteria can not only produce ethanol but also break it down into acetaldehyde. Oral taxa 273 
are known to be able to produce acetaldehyde from ethanol or glucose [74]. In addition, gut 274 
microbes can also produce acetaldehyde from sugars [75]. Indeed there have been reports 275 
of bacterial autobrewery syndrome (intoxication by ethanol formed by fermentation by 276 
microbes in the gut) in which a strain of Klebsiella pneumoniae was implicated [76]. This 277 
strain was also strongly associated with non-alcoholic fatty liver disease and fatty liver 278 
disease symptoms in a mouse model. Mutational signature 16 has been link to alcohol 279 
consumption [77].  280 
 281 
Disruption to the DNA damage response  282 
Human DNA experiences repeated events of DNA damage throughout the cell cycle. The cell 283 
has a complex network of systems whose purpose is to ensure the fidelity of DNA. Known as 284 
the DNA damage response, this cellular system is responsible for detecting DNA damage, 285 
signalling its presence, promoting DNA repair cell cycle checkpoint and/or apoptosis. 286 
The mismatch repair mechanism is responsible for addressing base-base mismatches and 287 
insertion/deletion mis-pairs generated during DNA replication and recombination[78].  288 
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Enteropathogenic Escherichia coli was found to promote the depletion of MSH2 and MLH1 289 
proteins, which are crucially important for mismatch repair in cell models[79]. This 290 
phenomenon was found to be dependent on the bacterial type-3 secretion effector 291 
EspF[79]. Furthermore, mitochondrial targeting of EspF was necessary for this activity. 292 
Colonic epithelial cells infected with Enteropathogenic E. coli display an increased mutation 293 
rate particularly in microsatellite DNA sequences. 294 
The human gastric pathogen Helicobacter pylori also inhibits the expression of MMR gene 295 
expression, in part through the modulation of miRNAs [80, 81]. 296 
 297 
Mutational signature 6 is characterised by C>T transitions at an NpCpG trinucleotide context 298 
[82]. This mutational signature is associated with small indels (usually 1-3bp) at nucleotide 299 
repeats. This indel pattern is equivalent to phenomena known as microsatellite instability. 300 
Microsatellite instability is caused by aberrations in the DNA mismatch repair (MMR) 301 
machinery. The origin of MMR deficiencies is genetic and/or epigenetic alterations in MMR 302 
genes. Microsatellite instability occurs in 15% of CRC genomes; 3% are associated with 303 
Lynch syndrome while 12% are associated with sporadic CRC [83]. 304 
 305 
Mutational signatures as a tool to study the effect of microbes on the human 306 
genome 307 
Multiomic experimental designs are supremely placed to delineate the relationship between 308 
the microbiota and the architecture of the cancer genome.  Population studies in which 309 
both cancer genomic and microbiome are assessed can provide information on the 310 
interaction between the cancer genetic architecture and the microbiota. However, there is a 311 
fundamental caveat with this type of experimental design. Cancer can take many years to 312 
form, and mutational mechanisms act at different time points of the natural tumour history. 313 
Furthermore, composition of the microbiota at most body sites is usually dynamic. Thus, a 314 
single snap shot of the microbiota may not be wholly related to the mutational signatures 315 
then identified. A prospective study where individual’s microbiota are determined at pre- 316 
and post-transformation stages would allow for more informative comparisons between the 317 
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microbiota and pre-transformation mutational mechanisms. Additionally, individuals with 318 
pre-cancer lesions such as Barrett’s oesophagus may be prime candidates to study due to 319 
their increased propensity to develop cancer. Studying cancer heterogeneity and 320 
evolutionary dynamics could allow for the identification of the timing of mutational 321 
mechanisms. Futhermore, recent advancements have allowed for mutational signature 322 
extraction from non-cancerous tissue thus allowing elucidation of microbial associated 323 
mechanisms prior to transformation [84]. Experiments in which a microbe or a community 324 
of microbes are grown in the context of a model such as a cell line or organoids would help 325 
to eliminate confounders and make more direct correlations. Dziubańska-Kusibab and 326 
colleagues used cultured cell lines exposed to colibactin to identify its DNA sequence 327 
targets. Furthermore this target sequence was then cross-referenced with mutational 328 
signatures derived in population cancer genomic data to find clinically associated mutational 329 





Concluding Remarks 335 
Cancer prevention is relatively under-researched when compared to therapeutic 336 
development, with only 2 to 9% of funding put towards this area [85]. A high proportion of 337 
cancer cases and cancer deaths could be avoided through modification of environmental 338 
risk factors. About 42% of cancer incidences in the US are estimated as being attributable to 339 
modifiable risk factors - this figure is also reflected in the UK population [86].  Evidence is 340 
building in favour of the microbiota as an environmental modulator of cancer risk. We 341 
outlined the multitude of ways that the metabolic activities of members of the human 342 
microbiota can lead to mutations. 343 
Our ability to modulate the microbiota is improving steadily, featuring diet, antibiotics, 344 
phage therapy, faecal microbiota transplantation (FMT), prebiotics, probiotics and Live 345 
Biotherapeutics[87].  Thus one could plausibly develop strategies to alter the structure of an 346 
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individual’s microbiota in order to reduce its mutagenic potential (see Outstanding 347 
Questions). 348 
In order to make informed decisions on therapeutic interventions, a complete catalogue of 349 
microbial-associated mutational mechanisms is required. Furthermore, the relative impact 350 
of each mutational mechanisms on the cancer genome need to be delineated.  Microbial-351 
associated mutational mechanisms which have both been found in a wide range of cancers 352 
as well as contributing to a great number of mutations will take priority when deciding what 353 
mechanisms need to be addressed first.  354 
We propose to leverage advancements in cancer genomics, namely in the form of 355 
mutational signatures, to associate microbes to mutational mechanisms.   These can provide 356 
qualitative and quantitative information on the mutagenic effect that microbes undoubtedly 357 
have. 358 
It is possible that certain aspects of the microbiota activity protect against mutagenesis and 359 
cancer.  These potential mechanism need to be elucidated to enable the harnessing the 360 
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 368 
Glossary 369 
Base substitutions:  A type of mutation in which one base is replaced by another in DNA. 370 
Chromosomal instability: A phenomena which leads to alterations in chromosome number 371 
and/or structure.  372 
DNA adduct: Formed by the addition of a chemical moiety to a DNA base 373 
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DNA alkylation: The addition of an alkyl group (CnH2n+1) to a DNA base  374 
DNA crosslinking: Formation of covalent bonds between two nucleotides. This bond can be 375 
formed between nucleotides on the same DNA stand (intrastrand crosslinks) or different 376 
strands (interstrand crosslinks) 377 
DNA deamination: The removal of an amino group from a DNA base.  378 
DNA repair: A diverse collection of pathways with the purpose of addressing DNA damage 379 
and maintaining genome stability.  380 
Double-strand breaks: This is where both strands of DNA which are juxtaposed to each 381 
other 382 
Environmental risk factor: A thing or process which is not inherited that increases the risk 383 
for a particular disease. 384 
Microbes: Microorganisms including bacteria, fungi, protists and virus. Usually exist as a 385 
single cell organism. 386 
Microbiome: The combined genetic material of the microorganisms in a particular niche. 387 
Microbiota: The collection of organisms in a niche. 388 
Mutational mechanism: Biological phenomena which lead to the generation of mutations. 389 
Usually involving DNA damage, DNA repair and DNA replication. 390 
Mutational signature: The characteristic DNA pattern of mutations produced by a 391 
mutational mechanism. 392 
Oncogenesis: The transformation of a normal cell into a cancer cell. 393 
Oxidative Base Lesions: DNA Bases that occur due to a reaction with Reactive oxygen 394 
species 395 







Box1 | Mutational signatures 401 
Specific mutational mechanisms produce characteristic patterns in the genome known as 402 
mutational signatures. Recent advances in mathematical modelling and bioinformatics have 403 
led to great improvements in our ability to identify mutational signatures from cancer 404 
genomic data. There are six defined classes of base substitutions: C>A, C>G, C>T, T>A, T>C 405 
and T>G [note: In accordance with the Catalogue of Somatic Mutations in Cancer (COSMIC) 406 
system, all substitutions are referred to by the pyrimidine of the mutated Watson-Crick base 407 
pair]. The incorporation of the 5’ and 3’ bases flanking the mutated base of the six originally 408 
defined classes gives an expanded classification system of 96 possible mutations. Utilizing 409 
this 96-class system as the framework and applying non-negative matrix factorization and 410 
model selection, with input from genomic data from 7042 cancer samples from 31 different 411 
cancer types, 21 mutational signatures were initially identified [82]. With the inclusion of 412 
more genomes for a heterogeneity of cancers, as well as the consideration of single base 413 
insertion/deletions and double base substitutions, the number of  mutational signatures has 414 
expanded[55]. Currently, the number and type of mutational signatures characterised are as 415 
follows: 49 single base substitutions, 11 doublet base substitutions, four clustered base 416 
substitutions (DBS), and 17 small insertion and deletion (indels) mutational signatures[55]. 417 
Structural variants also occur in cancer genomes and they include insertions, deletions, 418 
inversions, balanced or unbalanced translocations, amplifications and complex 419 
rearrangements on a scale of >50 bp in size[88].  Efforts have also been made to define the 420 
signatures of these events [89]. Mutational signatures provide an insight into the mutational 421 
mechanisms that act on a cancer genome over time.  Mutational signatures are typically 422 
displayed as histogram with the frequency of base substations (or indels or doublet base 423 
substitutions) with respect to the genomic context. SBS signature 1 is characterised by C>T 424 
transversions at methylated CpG sites within an NpCpG trinucleotide context. The putative 425 
mechanisms behind SBS signature 1 is spontaneous or enzymatic deamination of 5-426 
methylcytosine to thymine. This newly formed thymine maybe base-paired with adenine 427 
during replication, provided DNA repair is not executed.  Many mutational signatures 428 
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Box 2 | Oxidative DNA Base Lesions 437 
Guanine has the lowest redox potential of the native bases and is thus the most readily 438 
oxidised. Two common oxidative base lesions which are generated by the oxidation of 439 
Guanine include 8-oxo-7,8-dihydro-2’-deoxyguanosine and 2,6-diamino-4-oxo-5-440 
formamidopyrimidine (FapyG) which occur at an estimated rate of 1000–2000 and 1500–441 
2500  per cell/per day in normal tissues, respectively[91]. Furthermore, the occurrence and 442 
the mutagenicity of these oxidative DNA base lesions vary considerable. For example, 7,8-443 
dihydro-8-oxo-guanine is about four times as mutagenic and four times more frequent in its 444 
occurrence than 7,8-dihydro-8-oxo-adenine[91, 92]. Replication of DNA containing 8-oxo-445 
7,8-dihydro-2’-deoxyguanosine and 2,6-diamino-4-oxo-5-formamidopyrimidine (FapyG) are 446 
shown to induce G:C to T:A (C >A) and G:C to T:A (C >A) respectively[93]. 447 
The nucleobases within the cellular nucleotide pool may also undergo oxidation. 448 
Misincorporation of these nucleoside triphosphates can induce mutations. The two major 449 
products of nucleotide pool oxidation are 8-hydroxy-2′-deoxyguanosine 5′-triphosphate (8-450 
OH-dGTP) and 2‐hydroxydeoxyadenosine 5′‐triphosphate (2‐OH‐dATP).  8-OH-dGTP has 451 
been demonstrated to induce A:T to C:G transversions when introduced into COS-7 452 
mammalian cells[94]. In vitro analysis using HeLa cell extract showed that 2-OH-dATP within 453 
the nucleotide pool can led to G·C to A·T (C>T) transitions and G·C to T·A(C>A)[95].  454 
Mutational signatures 18 and 36 have been suggested to be attributed to reactive oxygen 455 
species. Mutational signature 36 has been specifically attributed to ROS in the context of 456 
MUTYH-Associated Polyposis (MAP) syndrome [90]. MAP syndrome is defined by biallelic 457 
germline mutation of MUTYH gene and is a colorectal polyposis which predisposes 458 
individuals to CRC. MUTYH DNA glycosylase is coded by the MUTYH gene and functions to 459 
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prevent 8-Oxoguanine-related mutagenesis by scanning  the newly-synthesized daughter 460 
strand in order locate and remove incorporated adenine paired with 8-Oxoguanine[93]. 461 
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